Clobazam and Pulmonary embolism for Boys aged 2-9 (a phase IV clinical study of FDA data)

Summary:

Pulmonary embolism is found for boys aged 2-9 who take Clobazam (clobazam). This study is created by eHealthMe based on reports of 933 boys aged 2-9 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Clobazam when people have Pulmonary embolism
Top conditions
Top co-used drugs
Top other side effects

On Aug, 12, 2026

933 boys aged 2-9 reported to have side effects when taking Clobazam.
Among them, 1 person (0.11%) has Pulmonary embolism

What is Clobazam?

Clobazam has active ingredients of clobazam. eHealthMe is studying from 14,399 Clobazam users. Check the latest studies of Clobazam.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,335 drugs and 2,959 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

Number of reports submitted per year:

Could Clobazam cause Pulmonary embolism in boys aged 2-9?

Severity of Pulmonary embolism

n/a

How people recovered from Pulmonary embolism

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 100.00%

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Clobazam and have Pulmonary embolism?

- Check whether Pulmonary embolism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Clobazam and Pulmonary embolism

How the study uses the data?

The study is based on (applicable) gender, age, clobazam (the active ingredients of Clobazam) and Clobazam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.